drugset / Trial / NCT00886756
AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This is a Phase I, double-blind, placebo-controlled, randomised within each dose group, single ascending dose study, with the objective to assess the safety, tolerability and pharmacokinetic profile of AZD8529 in healthy Japanese subjects.
Timeline
- Start
- 2009-04
- Primary completion
- —
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8529 | Other / unclassified | — | Oral |
Indications
No indication recorded.